Saturday, June 6, 2015

Cancer Research: Inflammation may promote the spread of cancer ♦ Triple treatment keeps cancer from coming back ♦ Intravenous nutrition source could reduce side effects of chemotherapy

Preexisting inflammation may promote the spread of cancer There is mounting evidence that chronic inflammation is linked to increased risk of tumor development. A new study is helping to shed light on the important link between inflammation and cancer, and how pre-existing inflammation may aid in the metastatic process.
Hodgkin's lymphoma: Rare case located outside of the nodules The case of a patient with Hodgkin's lymphoma located outside of the nodules has been published as a rare case study. There have been only 26 cases described like this in the scientific literature.
Triple treatment keeps cancer from coming back Lung cancer is the leading cause of cancer death worldwide, responsible for some 1.59 million deaths a year. That figure is due, in part, to the fact that the cancer often returns after what, at first, seems to be successful treatment, with recurring cancer often resistant to chemotherapy. A new strategy involving a three-pronged approach might keep an aggressive form of lung cancer from returning, scientists say.
Intravenous nutrition source could reduce side effects of chemotherapy A single dose of an FDA-approved intravenous nutrition source may be able to significantly reduce the toxicity and increase the bio availability of platinum-based cancer drugs, according to a study.
Pre-existing inflammation may promote the spread of cancer There is mounting evidence that chronic inflammation is linked to increased risk of tumor development. A new study is helping to shed light on the important link between inflammation and cancer, and how pre-existing inflammation may aid in the metastatic process.

No comments:

Post a Comment